Tokyo, Japan

Tazuo Uemura

This inventor holds 2 USPTO granted patents. Top assignee: Daiichi Pharmaceutical Co., Ltd.. Active years: 1996-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tazuo Uemura. Retrieved from https://idiyas.com/inventor/tazuo-uemura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1996-1997

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tazuo Uemura: Innovator in Antimicrobial Compounds

Introduction

Tazuo Uemura is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antimicrobial compounds. With a total of 2 patents, Uemura's work is recognized for its innovative approaches to crystallization processes.

Latest Patents

Uemura's latest patents include a method for selectively obtaining various hydrates of a specific antimicrobial compound. This method involves treating the compound in an aqueous solvent or recrystallizing it from water. Another patent details a process for selectively producing a specific carboxylic acid hemihydrate or monohydrate by controlling the water content during crystallization.

Career Highlights

Uemura is associated with Daiichi Pharmaceutical Co., Ltd., where he has been instrumental in advancing pharmaceutical research. His work has led to the development of methods that enhance the efficiency of producing important medicinal compounds.

Collaborations

Uemura has collaborated with notable coworkers, including Yukio Sato and Atsushi Sato. Their combined expertise has contributed to the success of various projects within the pharmaceutical industry.

Conclusion

Tazuo Uemura's innovative work in antimicrobial compounds showcases his dedication to advancing pharmaceutical science. His contributions continue to impact the field positively, highlighting the importance of research and development in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…